These studies support that detection of anti-VCM is as useful as the assays determining anti-CCP2 to distinguish RA from healthy controls [12, 13] and can help in the differential diagnosis of RA from other rheumatic disorders [14–16]. This evidence concerns the gene AGBL2 and rheumatic disorder.